1450KRW
35.10 BKRW
748.53 BKRW
11.82 M
About JW PHARMA
Sector
Headquarters
Seoul
Employees (FY)
1.15 K
Website
Founded
1945
ISIN
KR7001060003
FIGI
BBG000BDFM85
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote, antimicrobials, anticancer, antifungal, circulatory system, gastrointestinal, miscellaneous, multivitamins, and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory, obstetrics, gynecology, and nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 001060 is 29100 KRW — it has decreased by 2.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JW PHARMA stocks are traded under the ticker 001060.
JW PHARMA is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
001060 stock is 5.06% volatile and has beta coefficient of 1.31. Check out the list of the most volatile stocks — is JW PHARMA there?
One year price forecast for JW PHARMA has a max estimate of 49000 KRW and a min estimate of 40000 KRW.
JW PHARMA revenue for the last quarter amounts to 184.20 B KRW despite the estimated figure of 189.45 B KRW. In the next quarter revenue is expected to reach 206.70 B KRW.
Yes, you can track JW PHARMA financials in yearly and quarterly reports right on TradingView.
001060 stock has fallen by 5.37% compared to the previous week, the month change is a 9.49% fall, over the last year JW PHARMA has showed a 35.53% increase.
001060 net income for the last quarter is 23.69 B KRW, while the quarter before that showed −16.97 B KRW of net income which accounts for 239.56% change. Track more JW PHARMA financial stats to get the full picture.
Today JW PHARMA has the market capitalization of 662.67 B, it has decreased by 9.23% over the last week.
Yes, 001060 dividends are paid annually. The last dividend per share was 400.00 KRW. As of today, Dividend Yield (TTM)% is 1.38%. Tracking JW PHARMA dividends might help you take more informed decisions.
JW PHARMA dividend yield was 1.10% in 2023, and payout ratio reached 26.08%. The year before the numbers were 1.98% and 28.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 001060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JW PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.15 K employees. See our rating of the largest employees — is JW PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JW PHARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JW PHARMA stock shows the buy signal. See more of JW PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JW PHARMA future price: according to them, 001060 price has a max estimate of 49000.00 KRW and a min estimate of 40000.00 KRW. Read a more detailed JW PHARMA forecast: see what analysts think of JW PHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JW PHARMA EBITDA is 119.21 B KRW, and current EBITDA margin is 15.93%. See more stats in JW PHARMA financial statements.